(Q47449239)

16 January 2018

title

Diet, Weight Loss, and Cardiovascular Disease Prevention (English)

1 reference

16 January 2018

main subject

cardiovascular disease

1 reference

1

George A. Bray

1 reference

16 January 2018

Donna H. Ryan

2

1 reference

16 January 2018

David W. Harsha

series ordinal

3

1 reference

16 January 2018

publication date

1 August 2003

1 reference

16 January 2018

Current treatment options in cardiovascular medicine

published in

1 reference

16 January 2018

volume

5

1 reference

16 January 2018

issue

4

1 reference

16 January 2018

page(s)

259-269

1 reference

16 January 2018

https://scigraph.springernature.com/pub.10.1007/s11936-003-0025-9

exact match

0 references

cites work

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0025-9

Sibutramine produces dose-related weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0025-9

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0025-9

Differentiated long-term effects of intentional weight loss on diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-003-0025-9

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

21 January 2018

1 reference

12 December 2020

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

12 December 2020

Current and potential drugs for treatment of obesity

1 reference

12 December 2020

Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial

1 reference

12 December 2020

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial

1 reference

12 December 2020

Randomized, double-blind trial of chitosan for body weight reduction

1 reference

12 December 2020

Orlistat in the long-term treatment of obesity in primary care settings

1 reference

12 December 2020

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

1 reference

12 December 2020

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

1 reference

12 December 2020

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

1 reference

12 December 2020

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus

1 reference

12 December 2020

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial

1 reference

12 December 2020

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial

1 reference

12 December 2020

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

1 reference

12 December 2020

Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991

1 reference

12 December 2020

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

1 reference

12 December 2020

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial

1 reference

12 December 2020

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

1 reference

12 December 2020

Orlistat inhibits dietary cholesterol absorption

1 reference

12 December 2020

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

12 December 2020

Long-term weight loss with sibutramine: a randomized controlled trial

1 reference

12 December 2020

Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.

1 reference

12 December 2020

10.1007/S11936-003-0025-9

Identifiers

DOI

1 reference

16 January 2018

PubMed ID

12834563

1 reference

16 January 2018